Acura Pharmaceuticals Forecast and Stock Analysis
Technical ACUR stock analysis for March 22, 2019.
Acura Pharmaceuticals fell by -0.42% in the last day from $0.24 to $0.24 The price has fallen in 4 of the last 10 days , but is still up by 12.95% over the past 2 weeks. Volume has increased in the last day by 215 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 640 shares bought and sold for approximately $152.96.
Close price at the end of the last trading day (Friday, 22nd Mar 2019) of the ACUR stock was $0.24. This is 0.42% less than the trading day before Thursday, 21st Mar 2019.
During day the stock fluctuated 25.79% from a day low at $0.19 to a day high of $0.24.
30 day high of the ACUR stock price was $0.29 and low was $0.15.
90 day high was $0.29 and low was $0.06.
52 week high for the Acura Pharmaceuticals - $0.60 and low - $0.06.
Acura Pharmaceuticals lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 70.67% during the next 3 months and, with 90% probability hold a price between $0.32 and $0.50 at the end of this period.
Acura Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $0.23 and $0.21. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Tuesday March 19, 2019, which indicates further falls until a new bottom pivot has been found. Acura Pharmaceuticals gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 57 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $0.21 and $0.21.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Acura Pharmaceuticals finds support just below today's level at $0.21. If this is broken, then the next support from accumulated volume will be at $0.21 and $0.20.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.05 between high and low, or 25.79%. For the last week, the stock has had a daily average volatility of 11.79%.
Our recommended stoploss: $0.22 (-6.51%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 3 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.